Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin family members are cytokines and their receptors that regulate diverse aspects of immune function, inflammation, and cell signaling. The family includes pro-inflammatory, anti-inflammatory, and regulatory cytokines such as interleukin-1α, interleukin-1β, interleukin-18, interleukin-33, interleukin-36 variants, and members with receptor antagonist activity (e.g., IL-1Ra, IL-36Ra, IL-38). Their receptors form a corresponding family, including IL-1R1 to IL-1R10. Specific therapeutic agents have been developed for several interleukin ligands and receptors, especially in inflammation, autoimmune diseases, and cancer. Given the breadth of this family, entries should be specified for individual interleukins or their receptors rather than the family collectively for meaningful drug-target analysis.
Monoclonal antibody binding to interleukin ligand or receptor (e.g., anti-IL-1β, anti-IL-17A) Recombinant receptor antagonist (e.g., anakinra) Soluble decoy receptor (e.g., rilonacept)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin family members (IL family).